文献速递药疹与重症皮肤不良反应

重症皮肤不良反应表皮坏死松解症的临床与发病机制

Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN).
PubMed 文献 · J Eur Acad Dermatol Venereol · 2020-05-15

表皮坏死松解症(EN)包括中毒性表皮坏死松解症和较轻的Stevens-Johnson综合征,以角质形成细胞大量凋亡和/或坏死性凋亡导致表皮丢失为特征。EN常由药物通过半抗原、药理学相互作用或改变肽加载机制介导特异性TCR-HLA相互作用而诱发,CD8+ T细胞通过穿孔素/颗粒酶B、颗粒溶素及Fas/FasL杀伤角质形成细胞,或由CD14+单核细胞释放膜联蛋白经甲酰肽受体1诱导坏死性凋亡。遗传易感性研究旨在识别风险因素以预防EN,特定HLA I类等位基因关联最强,急性期后可有皮肤、眼、肝、肾等长期后遗症并影响生活质量。

要点

  • EN由药物介导TCR-HLA相互作用激活CD8+ T细胞杀伤角质形成细胞。
  • 特定HLA I类等位基因与EN关联最强,可用于风险因素研究。
  • EN急性期后可遗留皮肤、眼、肝、肾后遗症并影响生活质量。

核心结论

  • EN以角质形成细胞凋亡和/或坏死性凋亡致表皮丢失为特征,常由药物介导免疫反应引起。
  • EN可导致危及生命的全身效应和高死亡率,幸存者可有长期皮肤、眼、肝、肾后遗症及心理影响。

研究设计与样本

  • 本文为综述,总结EN的临床与发病机制方面,未报告系统检索范围或样本量。

主要发现

  • 药物通过半抗原、药理学相互作用或改变肽加载机制介导特异性TCR-HLA相互作用。
  • (记忆)CD8+ T细胞通过穿孔素/颗粒酶B、颗粒溶素及Fas/FasL杀伤角质形成细胞。
  • CD14+单核细胞释放膜联蛋白可经甲酰肽受体1诱导角质形成细胞坏死性凋亡。
  • 角质形成细胞死亡刺激局部炎症,激活其他免疫细胞产生促炎分子并下调调节性T细胞。
  • 特定HLA I类等位基因与EN关联最强,药物代谢、摄取、肽呈递及CD8+ T细胞功能相关基因也有风险变异。

关键数值与推荐

  • EN包括中毒性表皮坏死松解症和较轻的Stevens-Johnson综合征。
  • 黏膜后遗症表现为闭塞和狭窄,由裸露面粘连及黏膜炎症后纤维化所致。
  • 全身病理可导致急性和慢性肝、肾症状。

临床怎么用

  • 识别药物诱发的TCR-HLA相互作用及CD8+ T细胞毒性通路有助于理解EN发病。
  • 特定HLA I类等位基因检测可用于遗传易感性评估以预防EN。
  • EN急性期后需长期随访皮肤、眼、肝、肾及心理状态。

局限性

  • 本文为综述,未报告原始研究数据、样本量或检索策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The severe cutaneous adverse reaction epidermal necrolysis (EN) which includes toxic epidermal necrolysis and the milder Stevens-Johnson syndrome is characterized by epidermal loss due to massive keratinocyte apoptosis and/or necroptosis. EN is often caused by a drug mediating a specific TCR-HLA interaction via the (pro)hapten, pharmacological interaction or altered peptide loading mechanism involving a self-peptide presented by keratinocytes. (Memory) CD8 + T cells are activated and exhibit cytotoxicity against keratinocytes via the perforin/granzyme B and granulysin pathway and Fas/FasL interaction. Alternatively drug-induced annexin release by CD14 + monocytes can induce formyl peptide receptor 1 death of keratinocytes by necroptosis. Subsequent keratinocyte death stimulates local inflammation, activating other immune cells producing pro-inflammatory molecules and downregulating regulatory T cells. Widespread epidermal necrolysis and inflammation can induce life-threatening systemic effects, leading to high mortality rates. Research into genetic susceptibility aims to identify risk factors for eventual prevention of EN. Specific HLA class I alleles show the strongest association with EN, but risk variants have also been identified in genes involved in drug metabolism, cellular drug uptake, peptide presentation and function of CD8 + T cells and other immune cells involved in cytotoxic responses. After the acute phase of EN, long-term symptoms can remain or arise mainly affecting the skin and eyes. Mucosal sequelae are characterized by occlusions and strictures due to adherence of denuded surfaces and fibrosis following mucosal inflammation. In addition, systemic pathology can cause acute and chronic hepatic and renal symptoms. EN has a large psychological impact and strongly affects health-related quality of life among EN survivors.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Kuijper EC, French LE, Tensen CP, et al. Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN). J Eur Acad Dermatol Venereol. 2020. PMID: 32415695. doi:10.1111/jdv.16339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。